First Wilshire Securities Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $498K | Hold |
2,350
| – | – | 0.1% | 57 |
|
|
2026
Q1 | $461K | Hold |
2,350
| – | – | 0.1% | 59 |
|
|
2025
Q4 | $408K | Hold |
2,350
| – | – | 0.1% | 67 |
|
|
2025
Q3 | $448K | Hold |
2,350
| – | – | 0.12% | 62 |
|
|
2025
Q2 | $422K | Hold |
2,350
| – | – | 0.12% | 59 |
|
|
2025
Q1 | $398K | Hold |
2,350
| – | – | 0.11% | 57 |
|
|
2024
Q4 | $355K | Hold |
2,350
| – | – | 0.1% | 65 |
|
|
2024
Q3 | $365K | Hold |
2,350
| – | – | 0.1% | 62 |
|
|
2024
Q2 | $322K | Hold |
2,350
| – | – | 0.1% | 64 |
|
|
2024
Q1 | $313K | Hold |
2,350
| – | – | 0.09% | 69 |
|
|
2023
Q4 | $324K | Hold |
2,350
| – | – | 0.1% | 70 |
|
|
2023
Q3 | $286K | Hold |
2,350
| – | – | 0.1% | 72 |
|
|
2023
Q2 | $330K | Hold |
2,350
| – | – | 0.11% | 67 |
|
|
2023
Q1 | $332K | Hold |
2,350
| – | – | 0.11% | 68 |
|
|
2022
Q4 | $368K | Sell |
2,350
-100
| -4% | -$14.4K | 0.13% | 63 |
|
|
2022
Q3 | $301K | Hold |
2,450
| – | – | 0.12% | 65 |
|
|
2022
Q2 | $326K | Hold |
2,450
| – | – | 0.12% | 65 |
|
|
2022
Q1 | $335K | Hold |
2,450
| – | – | 0.12% | 65 |
|
|
2021
Q4 | $424K | Hold |
2,450
| – | – | 0.13% | 55 |
|
|
2021
Q3 | $356K | Hold |
2,450
| – | – | 0.12% | 63 |
|
|
2021
Q2 | $323K | Hold |
2,450
| – | – | 0.11% | 64 |
|
|
2021
Q1 | $314K | Hold |
2,450
| – | – | 0.12% | 65 |
|
|
2020
Q4 | $292K | Hold |
2,450
| – | – | 0.12% | 64 |
|
|
2020
Q3 | $281K | Hold |
2,450
| – | – | 0.13% | 65 |
|
|
2020
Q2 | $279K | Buy |
+2,450
| New | +$260K | 0.13% | 62 |
|
|
2020
Q1 | – | Sell |
-2,450
| Closed | -$262K | – | 85 |
|
|
2019
Q4 | $262K | Hold |
2,450
| – | – | 0.1% | 86 |
|
|
2019
Q3 | $262K | Hold |
2,450
| – | – | 0.1% | 88 |
|
|
2019
Q2 | $249K | Hold |
2,450
| – | – | 0.1% | 98 |
|
|
2019
Q1 | $220K | Hold |
2,450
| – | – | 0.08% | 109 |
|
|
2018
Q4 | $204K | Hold |
2,450
| – | – | 0.08% | 106 |
|
|
2018
Q3 | $264K | Hold |
2,450
| – | – | 0.08% | 105 |
|
|
2018
Q2 | $269K | Hold |
2,450
| – | – | 0.08% | 98 |
|
|
2018
Q1 | $246K | Hold |
2,450
| – | – | 0.07% | 107 |
|
|
2017
Q4 | $241K | Hold |
2,450
| – | – | 0.07% | 105 |
|
|
2017
Q3 | $229K | Hold |
2,450
| – | – | 0.06% | 107 |
|
|
2017
Q2 | $272K | Hold |
2,450
| – | – | 0.08% | 100 |
|
|
2017
Q1 | $241K | Hold |
2,450
| – | – | 0.07% | 101 |
|
|
2016
Q4 | $225K | Hold |
2,450
| – | – | 0.06% | 102 |
|
|
2016
Q3 | $207K | Buy |
+2,450
| New | +$206K | 0.06% | 104 |
|
Other funds holding DGX
EIG
First Wilshire Securities Management's DGX Position: Q2 2026 in Review
First Wilshire Securities Management held its Quest Diagnostics (DGX) position steady in Q2 2026 at 2,350 shares worth $498K. The position accounts for 0.1% of the portfolio, ranked #57.
First Wilshire Securities Management first reported a position in DGX in Q3 2016 and has held it in 39 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- First Wilshire Securities Management held 2,350 shares of Quest Diagnostics worth $498K as of Q2 2026.
- First Wilshire Securities Management left its Quest Diagnostics share count unchanged in Q2 2026.
- Quest Diagnostics made up 0.1% of First Wilshire Securities Management's portfolio in Q2 2026, its #57 holding.
- First Wilshire Securities Management first reported a position in Quest Diagnostics in Q3 2016 and has held it in 39 quarters since.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on First Wilshire Securities Management's 13F filing for Q2 2026, filed 14 Aug 2026.